Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;92(1100):20190001.
doi: 10.1259/bjr.20190001. Epub 2019 Jun 5.

Applications and limitations of machine learning in radiation oncology

Affiliations
Review

Applications and limitations of machine learning in radiation oncology

Daniel Jarrett et al. Br J Radiol. 2019 Aug.

Abstract

Machine learning approaches to problem-solving are growing rapidly within healthcare, and radiation oncology is no exception. With the burgeoning interest in machine learning comes the significant risk of misaligned expectations as to what it can and cannot accomplish. This paper evaluates the role of machine learning and the problems it solves within the context of current clinical challenges in radiation oncology. The role of learning algorithms within the workflow for external beam radiation therapy are surveyed, considering simulation imaging, multimodal fusion, image segmentation, treatment planning, quality assurance, and treatment delivery and adaptation. For each aspect, the clinical challenges faced, the learning algorithms proposed, and the successes and limitations of various approaches are analyzed. It is observed that machine learning has largely thrived on reproducibly mimicking conventional human-driven solutions with more efficiency and consistency. On the other hand, since algorithms are generally trained using expert opinion as ground truth, machine learning is of limited utility where problems or ground truths are not well-defined, or if suitable measures of correctness are not available. As a result, machines may excel at replicating, automating and standardizing human behaviour on manual chores, meanwhile the conceptual clinical challenges relating to definition, evaluation, and judgement remain in the realm of human intelligence and insight.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Number of search results by year for publications relating to “Radiation Oncology” and “Artificial Intelligence” or “Machine Learning”. Results from Google Scholar may represent a wider cross-section of publications than from PubMed. AI, Artificial Intelligence;ML, machine learning.
Figure 2.
Figure 2.
Schematic overview of the external beam radiation therapy workflow. Conceptually, we split this into (1) diagnosis and decision support, (2) treatment planning, and (3) treatment delivery. OAR, organ at risk.
Figure 3.
Figure 3.
Example of unedited segmentation of OARs. The use of automatic OAR segmentation based on deep learning methods has demonstrated time savings in the clinical workflow. OAR,organ at risk.

Comment in

References

    1. Bibault J-E, Giraud P, Burgun A. Big data and machine learning in radiation oncology: state of the art and future prospects. Cancer Lett 2016; 382: 110–7p.. doi: 10.1016/j.canlet.2016.05.033 - DOI - PubMed
    1. Feng M, Valdes G, Dixit N, Solberg TD. Machine learning in radiation oncology: opportunities, requirements, and needs. Frontiers in Oncology 2018; 8. doi: 10.3389/fonc.2018.00110 - DOI - PMC - PubMed
    1. Lustberg T, van Soest J, Jochems A, Deist T, van Wijk Y, Walsh S, et al. . Big data in radiation therapy: challenges and opportunities. Br J Radiol 2017; 90: 20160689. doi: 10.1259/bjr.20160689 - DOI - PMC - PubMed
    1. Meyer P, Noblet V, Mazzara C, Lallement A. Survey on deep learning for radiotherapy. Comput Biol Med 2018; 98: 126–46p.. doi: 10.1016/j.compbiomed.2018.05.018 - DOI - PubMed
    1. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, et al. . Artificial intelligence in radiation oncology: a specialty-wide disruptive transformation? Radiotherapy and Oncology 2018; 129: 421–6. doi: 10.1016/j.radonc.2018.05.030 - DOI - PMC - PubMed